Identification of pure urinary stone composition with the third generation dual-source dual-energy CT in vivo
MENG Xianghu1, QI Liang2, SUN Xueying2, CONG Rong1, WANG Zengjun1, SONG Rijin1
1Department of Urology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; 2Department of Radiology, First Affiliated Hospital of Nanjing Medical University
Abstract:Objective: To retrospectively evaluate the diagnostic accuracy of the third generation dual-source dual-energy computed tomography (DSDECT) for predicting the composition of pure urinary calculi in patients with urolithiasis vs. postoperative infrared spectroscopy (IRS) stone analysis. Methods: We retrospectively included 54 consecutive patients with 60 pure urinary stones diagnosed by IRS who underwent DSDECT from June 2018 to February 2020. Patients with known urolithiasis underwent preoperative DSDECT evaluation, and subsequently given surgical removal of the stones. The characteristics of these stones including 42 kidney stones, 17 ureter stones and one bladder stone scanned by DSDECT were recorded. The final determination of stone composition was made using IRS postoperatively. Results of the stone composition from DSDECT were compared to those from postoperative IRS stone analysis as the standard reference. Results: The average age of the patients enrolled in the study was (51.6 ± 13.8) y and average body mass index (BMI) was (25.5 ± 3.2) kg/m2. According to the results determined by IRS, 60 pure urinary calculi were divided into four groups: calcium oxalate, hydroxyapatite, uric acid and cystine stones. DSDECT could correctly detect uric acid and cystine stones compared to IRS analysis with accuracy of 100%. However, the accuracy for calcium oxalate and hydroxyapatite stones by DSDECT was only 63.3%. There was no statistically significant difference between ratio values of calcium oxalate (1.57 ± 0.06) and hydroxyapatite (1.55 ± 0.07) (P > 0.05) analyzed by DSDECT which were both significantly higher than those of uric acid (1.03 ± 0.04, P < 0.01) and cystine stones (1.33 ± 0.03, P < 0.01). Meanwhile, the CT values of calcium oxalate (1 317.53 ± 317.22) and (655.22 ± 203.04) HU detected by DSDECT under 100 kV and 150 kV were both higher than those of hydroxyapatite (963.56 ± 298.06) (P < 0.05) and (855.91 ± 198.37) HU (P < 0.01). Conclusion: In patients with pure urinary stones, DSDECT could predict uric acid and cystine stones with a satisfactory accuracy, but with a low accuracy for calcium oxalate and hydroxyapatite. It could help discriminate calcium oxalate and hydroxyapatite stones when combined with the stone characteristics detected by DSDECT.
孟祥虎, 祁良, 孙雪莹, 丛戎, 王增军, 宋日进. 第三代双源双能CT在体内预测单纯性泌尿系结石成分的临床应用价值[J]. 微创泌尿外科杂志, 2021, 10(1): 39-44.
MENG Xianghu, QI Liang, SUN Xueying, CONG Rong, WANG Zengjun, SONG Rijin. Identification of pure urinary stone composition with the third generation dual-source dual-energy CT in vivo. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2021, 10(1): 39-44.
[1] HESSE A, KRUSE R, GEILENKEUSER WJ, et al.Quality control in urinary stone analysis: results of 44 ring trials (1980-2001). Clin Chem Lab Med, 2005,43(3):298-303.
[2] ABDEL-HALIM RE, ABDEL-HALIM MR.A review of urinary stone analysis techniques. Saudi Med J, 2006,27(10):1462-1467.
[3] MANSOURI M, ARAN S, SINGH A, et al.Dual-energy computed tomography characterization of urinary calculi: basic principles, applications and concerns. Curr Probl Diagn Radiol, 2015,44(6):496-500.
[4] 郑媛慧,崔晓东.双源CT分析结石成分的临床应用进展.外科研究与新技术,2018,7(3):206-210.
[5] LI X, ZHAO R, LIU B, et al.Gemstone spectral imaging dual-energy computed tomography: a novel technique to determine urinary stone composition. Urology, 2013,81(4):727-730.
[6] ASCENTI G, SIRAGUSA C, RACCHIUSA S, et al.Stone-targeted dual-energy CT: a new diagnostic approach to urinary calculosis. AJR Am J Roentgenol, 2010,195(4):953-958.
[7] ZHANG GM, SUN H, XUE HD, et al.Prospective prediction of the major component of urinary stone composition with dual-source dual-energy CT in vivo. Clin Radiol, 2016,71(11):1178-1183.
[8] SCALES J, SMITH AC, HANLEY JM, et al.Prevalence of kidney stones in the United States. Eur Urol, 2012,62(1):160-165.
[9] MOE OW.Kidney stones: pathophysiology and medical management. Lancet, 2006,367(957):333-344.
[10] OUNISSI M, GARGUEH T, MAHFOUDHI M, et al.Nephrolithiasis-induced end stage renal disease. Int J Nephrol Renovasc Dis, 2010,3: 21-26.
[11] CORBO J, WANG J.Kidney and Ureteral Stones. Emerg Med Clin North Am, 2019,37(4):637-648.
[12] KAMPHUIS GM, WOUTER VJ, DE BIE P, et al.Method of alkalization and monitoring of urinary pH for prevention of recurrent uric acid urolithiasis: a systematic review. Transl Androl Urol, 2019,8(Suppl 4):S448-S456.
[13] PRIMAK A, FLETCHER JG, VRTISKA TJ, et al.Noninvasive differentiation of uric acid versus non-uric acid kidney stones using dual-energy CT. Acad Radiol, 2007,14(12):1441-1447.
[14] HABASHY D, XIA R, RIDLEY W, et al.Impact of dual energy characterization of urinary calculus on management. J Med Imaging Radiat Oncol, 2016,60(5):624-631.
[15] DUAN XH, LI ZB, YU LF, et al.Characterization of urinary stone composition by use of Third-Generation Dual-Source Dual-Energy CT with increased spectral separation. AJR Am J Roentgenol, 2015,205(6):1203-1207.
[16] ANANTHAKRISHNAN L, DUAN X, XI Y, et al.Dual-layer spectral detector CT: non-inferiority assessment compared to dual-source dual-energy CT in discriminating uric acid from non-uric acid renal stones ex vivo. Abdom Radiol (NY), 2018,43(11):3075-3081.
[17] NESTLER T, NESTLER K, NEISIUS A, et al.Diagnostic accuracy of third-generation dual-source dual-energy CT: a prospective trial and protocol for clinical implementation. World J Urol, 2019,37(4):735-741.
[18] 吴伟宙,黄健,梁雄发,等.单中心15269例泌尿系结石患者的结石成分分析.中华泌尿外科杂志,2018,39(9):651-655.
[19] LENG S, HUANG A, CARDONA JM, et al.Dual-energy CT for quantification of urinary stone composition in mixed stones: a phantom study. AJR Am J Roentgenol, 2016,207(2):321-329.
[20] GROßE HN, LENNARTZ S, SALEM J, et al. Dose independent characterization of renal stones by means of dual energy computed tomography and machine learning: an ex-vivo study. Eur Radiol, 2020,30(3):1397-1404.